Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Successful Allogeneic Alternative Donor Hematopoietic Stem Cell Transplantation in High-Risk Patients with Severe Sickle Cell Disease

Miriam Klahr, Amer Assal, Ran Reshef, Samuel S. Pan, Monica Bhatia, Diane George, Markus Y Mapara

Blood (2024) 144 (Supplement 1): 4886.

https://doi.org/10.1182/blood-2024-206449

Published: 2024

Journal Articles

The Impact of Hispanic Ethnicity on Disease Characteristics in Multiple Myeloma

Kara I. Cicero, Alfred I. Neugut, Andrew H. Doyle, Divaya Bhutani, Amer Assal, Ran Reshef, Markus Y. Mapara, Suzanne Lentzsch, Rajshekhar Chakraborty

Blood (2022) 140 (Supplement 1): 8026–8027.

https://doi.org/10.1182/blood-2022-166491

Published: 2022

Journal Articles

RGI-2001 Infusion for Prevention of Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation

Yi-Bin Chen, Ayman Saad, Shatha Y. Farhan, Lazaros J. Lekakis, Gary J. Schiller, Jean A. Yared, Amer Assal, Dana D Lee, Hayley Lane, Ted A. Gooley, Zachariah Defilipp

Blood (2022) 140 (Supplement 1): 1877–1878.

https://doi.org/10.1182/blood-2022-162512

Published: 2022

Journal Articles

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Divaya Bhutani, MD, Christian Gordillo, BS, Suzanne Lentzsch, MD PhD, Ran Reshef, MDMSc, Markus Y Mapara, MD PhD

Blood (2019) 134 (Supplement_1): 2043.

https://doi.org/10.1182/blood-2019-132113

Published: 2019

Journal Articles

Autologous Transplant Recipients Have a Healthier Gut Microbiota at Baseline and Faster Recovery from Microbiome Injury Compared to Allogeneic Transplant Recipients

Rajat Bansal, MD, Heekuk Park, Cristian Taborda, Christian Gordillo, BS, Markus Y. Mapara, MD PhD, Amer Assal, MD, Anne-Catrin Uhlemann, MD, Ran Reshef, MDMSc

Blood (2019) 134 (Supplement_1): 4491.

https://doi.org/10.1182/blood-2019-129304

Published: 2019

Journal Articles

Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Phase I/II Study

Divaya Bhutani, MD, Siyang Leng, MD, Samuel Pan, Amer Assal, MD, Alexander Wei, Julia Gould, BA, Markus Y. Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2019) 134 (Supplement_1): 3196.

https://doi.org/10.1182/blood-2019-130207

Published: 2019

Journal Articles

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Christian Gordillo, BS, Nicole Howard, BS, Ran Reshef, MD MSc, Markus Y Mapara, MD PhD

Blood (2018) 132 (Supplement 1): 5713.

https://doi.org/10.1182/blood-2018-99-116538

Published: 2018

Journal Articles

An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients

Siyang Leng, MD, Shahzad Raza, MD, Amer Assal, MD, Gregory Baliko, BS, Julia Gould, BA, Rachel K Shields, BA, Markus Y Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2017) 130 (Supplement 1): 1863.

https://doi.org/10.1182/blood.V130.Suppl_1.1863.1863

Published: 2017

Journal Articles

Gastrointestinal Toxicity of High-Dose Melphalan in Autologous Stem-Cell Transplantation: Identification of Risk Factors and a Benchmark for Experimental Therapies

Christian Gordillo, BS, Sapna Parmar, PharmD, Miranda Blanco, BS, Elsa Marie Delille, NP, Amer Assal, MD, Markus Y Mapara, MD PhD, Ran Reshef, MDMSc

Blood (2017) 130 (Supplement 1): 5464.

https://doi.org/10.1182/blood.V130.Suppl_1.5464.5464

Published: 2017

Journal Articles

HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Justin Kaner, MD, Santiago Thibaud, MD, Ashwin Sridharan, MD, Amer Assal, MD, Rahul Polineni, MD, Barry Zingman, MD, Anjali Sharma, MD, Harold Kunal Elias, MD, Louis Weiss, MD MPH, Murali Janakiram, MD, Ira Braunschweig, MD, Swati Goel, MD, Ulrich Steidl, MDPhD, Kith Pradhan, PhD, Aditi Shastri, MD, Britta Will, PhD, Ioannis Mantzaris, MD, Mark Chaitowitz, MD, Amit Verma, MD

Blood (2016) 128 (22): 4345.

https://doi.org/10.1182/blood.V128.22.4345.4345

Published: 2016

Journal Articles

Plasmablastic Lymphoma : A Case Series of the Changing Epidemiology of a Rare Extramedullary Plasmacytoid Neoplasm, Diagnostic Challenges, and Therapeutic Implications

Lisa X. Lee, MD, Bhavana Konda, MDMPH, Amer Assal, MD, Monica I Zell, Ira Braunschweig, MD, Olga Derman, MD, Noah Kornblum, MD, Amit Verma, MD, Ramakrishna Battini, MD, Murali Janakiram, MD

Blood (2014) 124 (21): 2995.

https://doi.org/10.1182/blood.V124.21.2995.2995

Published: 2014

Journal Articles

Ovarian Vein Thrombosis: Clinical Features, Risk Factors, and Outcomes

Amer Assal, MD, Justin D Kaner, MD, Neeraja Danda, MBBS, Henny H Billett, MD

Blood (2014) 124 (21): 587.

https://doi.org/10.1182/blood.V124.21.587.587

Published: 2014

Journal Articles

Outcomes and Treatment Patterns of Patients with CML in an Inner-City, Underserved, Multi-Ethnic Patient Cohort Reveals Good Overall Survival with Both First and Second Generation TKIs As Initial Therapy

Amer Assal, MD, Ramadevi Medavarapu, MD, Ellen W Friedman, MD, Yiting Yu, PhD, Amit Verma, MD, Olga Derman, MD

Blood (2014) 124 (21): 5522.

https://doi.org/10.1182/blood.V124.21.5522.5522

Published: 2014

Journal Articles

Analysis of Large Cohort Shows That Caribbean Adult T Cell Leukemia/Lymphoma Is a Chemotherapy Refractory Disease with Very Poor Prognosis That Behaves Distinctly from Japanese Subtypes

Monica I Zell, Amer Assal, MD, Bhavana Konda, MDMPH, Ira Braunschweig, MD, Olga Derman, MD, Noah Kornblum, MD, Ramakrishna Battini, MD, Amit Verma, MD, Murali Janakiram, MD

Blood (2014) 124 (21): 1685.

https://doi.org/10.1182/blood.V124.21.1685.1685

Published: 2014

NARROW

Successful Allogeneic Alternative Donor Hematopoietic Stem Cell Transplantation in High-Risk Patients with Severe Sickle Cell Disease

The Impact of Hispanic Ethnicity on Disease Characteristics in Multiple Myeloma

RGI-2001 Infusion for Prevention of Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Autologous Transplant Recipients Have a Healthier Gut Microbiota at Baseline and Faster Recovery from Microbiome Injury Compared to Allogeneic Transplant Recipients

Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Phase I/II Study

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients

Gastrointestinal Toxicity of High-Dose Melphalan in Autologous Stem-Cell Transplantation: Identification of Risk Factors and a Benchmark for Experimental Therapies

HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Plasmablastic Lymphoma : A Case Series of the Changing Epidemiology of a Rare Extramedullary Plasmacytoid Neoplasm, Diagnostic Challenges, and Therapeutic Implications

Ovarian Vein Thrombosis: Clinical Features, Risk Factors, and Outcomes

Outcomes and Treatment Patterns of Patients with CML in an Inner-City, Underserved, Multi-Ethnic Patient Cohort Reveals Good Overall Survival with Both First and Second Generation TKIs As Initial Therapy

Analysis of Large Cohort Shows That Caribbean Adult T Cell Leukemia/Lymphoma Is a Chemotherapy Refractory Disease with Very Poor Prognosis That Behaves Distinctly from Japanese Subtypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only